Nosocomial infection incidence in patients after hepatic transplantation

Por Martin, MM, Colmenero, C, Lorente, L, Molina, I, Trujillo, A, Chopitea, A
Publicado em 2003

Combining chemotherapy and targeted therapies in metastatic colorectal cancer

Por Rodriguez, J, Zarate, R, Bandres, E, Viudez, A, Chopitea, A, García-Foncillas, J, Gil-Bazo, I
Publicado em 2007

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: What’s new?

Por Ponz-Sarvisé, M, Rodríguez, J, Viudez, A, Chopitea, A, Calvo, A, García-Foncillas, J, Gil-Bazo, I
Publicado em 2007

Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients

Por Abajo, A, Rodriguez, J, Bitarte, N, Zarate, R, Boni, V, Ponz, M, Chopitea, A, Bandres, E, Garcia-Foncillas, J
Publicado em 2010

Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis

Por Zarate, R, Rodríguez, J, Bandres, E, Patiño-Garcia, A, Ponz-Sarvise, M, Viudez, A, Ramirez, N, Bitarte, N, Chopitea, A, Gacía-Foncillas, J
Publicado em 2010